Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma Download PDFPublished at Sat, 03 Apr 2021 04:54:36 +0000
Read More
Anupam Kher Shares Kirron Kher’s Message For Netizens After Cancer Diagnosis; Celebs React Anupam Kher conveyed gratitude to his fans and followers for their wishes for Kirron Kher’s health after she was diagnosed with myeloma, a type of blood cancer. The actor wrote that the Bharatiya Janata Party Member of Parliament from Chandigarh had conveyed […]
Read More Unravelling the secret of a critical immune cell for cancer immunity IMAGE: DC-SCRIPT positive cells (red) activating an immune response (blue T cells). view more Credit: Shengbo Zhang and Wang Cao, WEHI WEHI researchers have discovered a key differentiation process that provides an essential immune function in helping to control cancer and infectious diseases. The research, […]
Read More
What to Know About Colorectal Cancer If cancer forms in a polyp, it grows into the wall of the colon or rectum. It starts in the inner layers (known as the mucosa), then grows outward through all the other layers. Eventually, it can grow into blood or lymph vessels, where it can travel to lymph […]
Read More
NKMax Rebrands As NKGen Ahead of Next Clinical Trial Launch, Off-The-Shelf Testing Days after announcing the U.S. Food and Drug Administration (FDA) has cleared the next clinical trials to launch for its lead natural killer (NK) cell therapies, NKMax America announced it has renamed itself NKGen Biotech to better align with its core focus and […]
Read More Melphalan Market 2021 – Suitable Circumstance Global Melphalan Industry: with growing significant CAGR during 2021-2026 New Research Report on Melphalan Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis Understand the influence of COVID-19 on the Melphalan Market with our analysts monitoring the situation across the globe. Request […]
Read More
Conversation with The Cancer Letter publication date: Apr. 2, 2021 Issue 13 – Apr. 2, 2021 To access this members-only content, please log in.Institutional subscribers, please log in with your IP.If you’re not a subscriber why not join today? To gain access to the members only content click here to subscribe.You will be given immediate […]
Read More
Research finds possible explanation for why many cancer drugs don’t work in human trials A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and […]
Read More
Study finds why some cancer drugs may be ineffective Washington [US], April 1 (ANI): A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and […]
Read More
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy Children and young adults who receive CAR T-cell therapy for the most common childhood cancer – acute lymphoblastic leukemia – suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a […]
Read More